Delivery Order SPE2DB22D1103-SPE2DB25FTFE6
Award Date
2/5/25
Potential Completion Date
2/6/25
Potential Value
$1.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. government has awarded a Delivery Order contract worth $5,894.80 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, issued by the Defense Logistics Agency (DLA) Troop Support Medical, is for the supply of the pharmaceutical product XCOPRI 50 MG TABLET 30S. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA, which serves as a primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply the drug XCOPRI 50 MG TABLET 30S. The contract has a ceiling value of $1,082.68 and a period of performance ending on July 2, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the provision of the pharmaceutical product XCOPRI 100 MG TABLET 30S, with a ceiling value of $1,937.10 and a period of performance through April 26, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the federal government, holds a $999,999,999.00 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,476.24 firm fixed-price delivery order is for the supply of XCOPRI 150 MG tablets to support military healthcare programs. The contract has an ultimate completion date of January 17, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This is a delivery order award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,624.02 firm fixed price contract is for the delivery of the drug XCOPRI 150 MG TABLET 30S, with a completion date of May 4, 2023. This award is not associated with a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,055.63 firm fixed-price delivery order is for the supply of the prescription medication XCOPRI 50 MG TABLET 30S. The contract is not designated as a set-aside and has an ultimate completion date of December 12, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,073.76, is a Delivery Order issued by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of XCOPRI 200 MG TABLET 30S, a pharmaceutical product, with a period of performance through January 10, 2025. This contract award is not designated as a set-aside. In addition to this Delivery Order,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,774.84 Firm Fixed Price Delivery Order covers the supply of the pharmaceutical product XCOPRI 50 MG TABLET 30S. The contract has a completion date of February 4, 2025 and does not utilize any set-aside designations, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,699.87, is for the delivery of XCOPRI 200 MG TABLET 30S, a specialty pharmaceutical product. The contract has an ultimate completion date of January 8, 2025. AmerisourceBergen has previously been awarded an Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $1,361.78, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The contract is for the delivery of XCOPRI 50 MG TABLET 30S, a specialty medication, to support medical needs across military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract is a Firm Fixed Price Delivery Order that runs through January 27, 2025. It is not...